KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bristol Myers Squibb (BMY) Total Liabilities (2016 - 2025)

Historic Total Liabilities for Bristol Myers Squibb (BMY) over the last 17 years, with Q3 2025 value amounting to $78.3 billion.

  • Bristol Myers Squibb's Total Liabilities rose 237.87% to $78.3 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $78.3 billion, marking a year-over-year increase of 237.87%. This contributed to the annual value of $76.2 billion for FY2024, which is 1605.05% up from last year.
  • As of Q3 2025, Bristol Myers Squibb's Total Liabilities stood at $78.3 billion, which was up 237.87% from $77.2 billion recorded in Q2 2025.
  • Bristol Myers Squibb's Total Liabilities' 5-year high stood at $82.5 billion during Q1 2024, with a 5-year trough of $61.5 billion in Q2 2023.
  • In the last 5 years, Bristol Myers Squibb's Total Liabilities had a median value of $73.6 billion in 2021 and averaged $71.6 billion.
  • Its Total Liabilities has fluctuated over the past 5 years, first tumbled by 1259.86% in 2023, then soared by 3219.49% in 2024.
  • Quarter analysis of 5 years shows Bristol Myers Squibb's Total Liabilities stood at $73.3 billion in 2021, then fell by 10.38% to $65.7 billion in 2022, then decreased by 0.04% to $65.7 billion in 2023, then grew by 16.05% to $76.2 billion in 2024, then rose by 2.72% to $78.3 billion in 2025.
  • Its Total Liabilities stands at $78.3 billion for Q3 2025, versus $77.2 billion for Q2 2025 and $75.0 billion for Q1 2025.